Eli Lilly & Co. (LLY) Misses Q4 EPS by 1c, Revenue Beats, FY19 EPS Guidance Misses
Eli Lilly & Co. (NYSE: LLY) reported Q4 EPS of $1.33, $0.01 worse than the analyst estimate of $1.34. Revenue for the quarter came in at $6.44 billion versus the consensus estimate of $6.28 billion.
Eli Lilly & Co. sees FY2019 EPS of $5.55-$5.65, versus the consensus of $5.77.
For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.